7-130322526-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_016352.4(CPA4):c.1116C>A(p.Asp372Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000322 in 1,614,112 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_016352.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CPA4 | NM_016352.4 | c.1116C>A | p.Asp372Glu | missense_variant | 11/11 | ENST00000222482.10 | |
LOC105375503 | XR_001745362.2 | n.104-1761G>T | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CPA4 | ENST00000222482.10 | c.1116C>A | p.Asp372Glu | missense_variant | 11/11 | 1 | NM_016352.4 | P1 | |
CPA4 | ENST00000445470.6 | c.1017C>A | p.Asp339Glu | missense_variant | 10/10 | 2 | |||
CPA4 | ENST00000493259.5 | c.804C>A | p.Asp268Glu | missense_variant | 9/9 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000315 AC: 48AN: 152168Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000450 AC: 113AN: 251228Hom.: 0 AF XY: 0.000538 AC XY: 73AN XY: 135766
GnomAD4 exome AF: 0.000323 AC: 472AN: 1461826Hom.: 1 Cov.: 34 AF XY: 0.000364 AC XY: 265AN XY: 727226
GnomAD4 genome AF: 0.000315 AC: 48AN: 152286Hom.: 0 Cov.: 32 AF XY: 0.000363 AC XY: 27AN XY: 74458
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 14, 2021 | The c.1116C>A (p.D372E) alteration is located in exon 11 (coding exon 11) of the CPA4 gene. This alteration results from a C to A substitution at nucleotide position 1116, causing the aspartic acid (D) at amino acid position 372 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at